M J Sculpher
Overview
Explore the profile of M J Sculpher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oddershede L, Walker S, Paton N, Stohr W, Dunn D, Sculpher M
Value Health
. 2016 May;
17(7):A683.
PMID: 27202527
No abstract available.
2.
Ross Terres J, Lozano-Ortega G, Kendall R, Sculpher M
BMC Cardiovasc Disord
. 2015 Dec;
15:180.
PMID: 26715178
Background: Acute coronary syndrome (ACS) refers to a spectrum of life-threatening cardiac diseases usually due to coronary artery plaque rupture, subsequent thrombin generation plaque activation and thrombus formation. To date,...
3.
Epstein D, Sculpher M, Powell J, Thompson S, Brown L, Greenhalgh R
Br J Surg
. 2014 Mar;
101(6):623-31.
PMID: 24664537
Background: A number of published economic evaluations of elective endovascular aneurysm repair (EVAR) versus open repair for abdominal aortic aneurysm (AAA) have come to differing conclusions about whether EVAR is...
4.
Pitman R, Nagy L, Sculpher M
Vaccine
. 2012 Dec;
31(6):927-42.
PMID: 23246550
This study uses a dynamic influenza transmission model to directly compare the cost-effectiveness of various policies of annual paediatric influenza vaccination in England and Wales, varying the target age range...
5.
The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy
Brown L, Powell J, Thompson S, Epstein D, Sculpher M, Greenhalgh R
Health Technol Assess
. 2012 Mar;
16(9):1-218.
PMID: 22381040
Objective: To assess the efficacy of endovascular aneurysm repair (EVAR) against standard alternative management in patients with large abdominal aortic aneurysm (AAA). Design: Two national, multicentre randomised trials - EVAR...
6.
Campbell H, Epstein D, Bloomfield D, Griffin S, Manca A, Yarnold J, et al.
Eur J Cancer
. 2011 Jul;
47(17):2517-30.
PMID: 21741831
Background: The risk of recurrence following surgery in women with early breast cancer varies, depending upon prognostic factors. Adjuvant chemotherapy reduces this risk; however, increasingly effective regimens are associated with...
7.
Henriksson M, Epstein D, Palmer S, Sculpher M, Clayton T, Pocock S, et al.
Heart
. 2007 Nov;
94(6):717-23.
PMID: 18032459
Background: Evidence suggests that an early interventional strategy for patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) can improve health outcomes but also increase costs when compared with a conservative strategy....
8.
Bravo Vergel Y, Hawkins N, Claxton K, Asseburg C, Palmer S, Woolacott N, et al.
Rheumatology (Oxford)
. 2007 Oct;
46(11):1729-35.
PMID: 17956918
Objective: Tumour necrosis factor (TNF) antagonists have been shown to improve the outcomes in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). We assess the cost-effectiveness of two TNF...
9.
Epstein D, Sculpher M, Manca A, Michaels J, Thompson S, Brown L, et al.
Br J Surg
. 2007 Sep;
95(2):183-90.
PMID: 17876749
Background: Recent randomized trials have shown that endovascular abdominal aortic aneurysm repair (EVAR) has a 3 per cent aneurysm-related survival benefit in patients fit for open surgery, but it also...
10.
Griffin S, Barber J, Manca A, Sculpher M, Thompson S, Buxton M, et al.
BMJ
. 2007 Mar;
334(7594):624.
PMID: 17339236
Objective: To assess whether revascularisation that is considered to be clinically appropriate is also cost effective. Design: Prospective observational study comparing cost effectiveness of coronary artery bypass grafting, percutaneous coronary...